Pharmalot

Pharmalot Ed Silverman

STAT Plus: Oregon suspends a portion of its drug transparency law found to be unconstitutional

Pharmalot Rachel Cohrs and Ed Silverman

STAT Plus: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharma Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more

Pharmalot Ed Silverman

STAT Plus: FDA gives a mixed response to a petition seeking greater clinical trial transparency

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more

Pharmalot Ed Silverman

STAT Plus: Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $475 million

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more

Pharmalot Ed Silverman

STAT Plus: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more

Pharmalot Ed Silverman

STAT Plus: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more

Pharmalot Ed Silverman

STAT Plus: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines

Pharmalot Ed Silverman and John Wilkerson

STAT Plus: FTC to probe the role of middlemen in worsening drug shortage crisis

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a tossed PhRMA lawsuit, secrecy clauses, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more

Pharmalot Ed Silverman

STAT Plus: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more

Pharmalot Ed Silverman

STAT Plus: Years into an addiction crisis, a med school lecture still minimized opioid risks

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about worries over a Novo deal, a PBM bill, and more

Pharmalot Ed Silverman

STAT Plus: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a lawsuit against J&J, Express Scripts dealings, and more

Pharmalot Bob Herman and Ed Silverman

STAT Plus: A sweeping new lawsuit against J&J asks: Are employers liable if they overpay for drugs?

Pharmalot Ed Silverman

STAT Plus: Diabetes treatments have improperly listed patents that should be removed, analysis finds